PRELIMINARY RESULTS OF A PHASE 2 TRIAL OF OBINUTUZUMAB, IN COMBINATION WITH IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (O-ICE) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED/ REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA. (October 2022) - Hochberg, J.; Cohen, M.; Barth, M.; Harrison, L.; Klejmont, L.; Shi, Q.; Goldman, S.; Galardy, P.; Perkins, S.; Miles, R.; Lim, M.; Cairo, M.